Marco Antonio Moreira Puga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marco Antonio Moreira Puga has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Ana Rita Coimbra Motta-Castro
Universidade Federal de Mato Grosso do Sul
11 shared publications - Larissa Melo Bandeira
Affiliation Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
9 shared publications - Julio Croda
School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil
5 shared publications - Sabrina Moreira dos Santos Weis-Torres
Laboratory of Clinical Immunology, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, Brazil
5 shared publications - Rivaldo Venâncio da Cunha
Fundação Oswaldo Cruz, Brazil
4 shared publications - Sheila Araújo Teles
Universidade Federal de Goiás, Brazil
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Enfermagem
- Vol. 79
Cervical cancer screening in incarcerated women: deprived of freedom or deprived of health?
Objectives: to reflect on and discuss the reality of cervical cancer screening among incarcerated women. Methods: theoretical-reflective study, developed from a previous review of the scientific and documentary literature on cervical cancer screening programs, encompassing international, Latin American, and Brazilian experiences. The analysis and reflection were conducted critically, aiming to identify advances, limitations, and gaps in screening and treatment strategies. Results: although the prison environment facilitates the development of cervical cancer screening actions, as it contributes to access to women, they have a lower chance of being investigated, indicating a possible irregularity in the supply, suggesting a weakness and inconsistency in healthcare. The purpose of incarceration may be to deprive offenders of freedom, but not to deny their rights to health. Final Considerations: the reflections presented here emphasize the importance of nursing in conducting screening, follow-up, and health education actions, particularly among populations in situations of greater vulnerability.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Enfermagem
- Vol. 79
Open AccessCervical cancer screening in incarcerated women: deprived of freedom or deprived of health?
Objectives: to reflect on and discuss the reality of cervical cancer screening among incarcerated women. Methods: theoretical-reflective study, developed from a previous review of the scientific and documentary literature on cervical cancer screening programs, encompassing international, Latin American, and Brazilian experiences. The analysis and reflection were conducted critically, aiming to identify advances, limitations, and gaps in screening and treatment strategies. Results: although the prison environment facilitates the development of cervical cancer screening actions, as it contributes to access to women, they have a lower chance of being investigated, indicating a possible irregularity in the supply, suggesting a weakness and inconsistency in healthcare. The purpose of incarceration may be to deprive offenders of freedom, but not to deny their rights to health. Final Considerations: the reflections presented here emphasize the importance of nursing in conducting screening, follow-up, and health education actions, particularly among populations in situations of greater vulnerability.
- Open Access
- 22 July 2025
- Published by Instituto Adolfo Lutz in Revista Do Instituto Adolfo Lutz
- Vol. 84, 1-11
HTLV infection in inmates with active tuberculosis in Mato Grosso do Sul, Brazil
Human T-cell lymphotropic virus (HTLV) is a retrovirus with a worldwide presence that may influence tuberculosis (TB) pathogenesis, particularly in populations where both infections are prevalent. This cross-sectional study aimed to estimate the prevalence of HTLV-1/2 infection among inmates with TB in Mato Grosso do Sul (MS) State, Central Brazil. Male individuals with bacteriologically confirmed active TB were recruited from two major closed male penal institutions in MS State: Instituto Penal de Campo Grande (IPCG) and Estabelecimento Penal Jair Ferreira de Carvalho (EPJFC). Serum samples were screened for anti-HTLV-1/2 antibodies using enzyme-linked immunosorbent assay (ELISA), and positive samples were confirmed by HTLV-1/2 Western Blot (WB) assay. A total of 279 inmates participated in the study. Two participants (0.72%; 95% CI 0.18 –2.84) initially tested positive for anti HTLV by ELISA. One patient was confirmed to have HTLV-1 infection by WB, along with active syphilis, while the other showed an indeterminate WB result and tested positive for anti HIV and anti-HCV. Although the overall HTLV prevalence in the sample was relatively low, this study underscores the potential for HTLV and TB co-infection in high-risk populations such as inmates.
- 22 July 2025
- Published by Instituto Adolfo Lutz in Revista Do Instituto Adolfo Lutz
- Vol. 84, 1-11
Open AccessHTLV infection in inmates with active tuberculosis in Mato Grosso do Sul, Brazil
Human T-cell lymphotropic virus (HTLV) is a retrovirus with a worldwide presence that may influence tuberculosis (TB) pathogenesis, particularly in populations where both infections are prevalent. This cross-sectional study aimed to estimate the prevalence of HTLV-1/2 infection among inmates with TB in Mato Grosso do Sul (MS) State, Central Brazil. Male individuals with bacteriologically confirmed active TB were recruited from two major closed male penal institutions in MS State: Instituto Penal de Campo Grande (IPCG) and Estabelecimento Penal Jair Ferreira de Carvalho (EPJFC). Serum samples were screened for anti-HTLV-1/2 antibodies using enzyme-linked immunosorbent assay (ELISA), and positive samples were confirmed by HTLV-1/2 Western Blot (WB) assay. A total of 279 inmates participated in the study. Two participants (0.72%; 95% CI 0.18 –2.84) initially tested positive for anti HTLV by ELISA. One patient was confirmed to have HTLV-1 infection by WB, along with active syphilis, while the other showed an indeterminate WB result and tested positive for anti HIV and anti-HCV. Although the overall HTLV prevalence in the sample was relatively low, this study underscores the potential for HTLV and TB co-infection in high-risk populations such as inmates.
- Open Access
- 5 July 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e002331
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil
Objectives: To compare antispike IgG levels over a period of 182 days of follow-up in healthy adults who received full or fractional booster doses of BNT162b2 or AZD1222 after completing a primary series of Sinovac, BNT162b2 or AZD1222. Design: Double-blind, parallel-arm, phase IV randomised trial. Setting: The study was conducted in Campo Grande, Brazil, and participants were recruited in neighbourhoods with the lowest booster vaccine coverage. Follow-up visits were home based. Participants: 1451 (18–60 years) healthy adults who had received a full primary series of Sinovac (n=549), BNT162b2 (n=451) or AZD1222 (n=451) were included. Interventions: Participants were randomised to receive booster doses of either full or fractional doses of BNT162b2, AZD1222 or a full dose of Sinovac in the Sinovac-primed group. Antispike IgG antibody levels were measured at 0, 28, 84 and 182 days post-booster. Main outcome measures: Antispike IgG antibody levels were measured through blood samples at baseline and follow-up visits that were conducted 28, 84 and 182 days post-booster vaccination. Results: Throughout the 182-day follow-up period, full doses of BNT162b2 generated the highest antibody titres compared with fractional doses and other vaccines in all primary groups. Full-dose AZD1222 compared with its fractional dose showed a substantial difference only at day 28. BNT162b2 fractional doses produced higher antibodies than AZD1222 full doses. Sinovac-primed participants had the lowest baseline antibody titres, with Sinovac boosters continuing to show low titres, compared with BNT162b2 or AZD1222 full or fractional doses. Conclusions: Full doses of BNT162b2 consistently elicited higher antibody titres than fractional doses, AZD1222 and Sinovac at all time points. AZD1222 and Sinovac full doses produced lower titres than BNT162b2 fractional doses. Recommendations for using fractional doses of BNT162b2 as an alternative to full doses should be made cautiously, and further studies are needed to determine clinical protection levels. Trial registration number: NCT05343871 .
- 5 July 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e002331
Open AccessAntispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil
Objectives: To compare antispike IgG levels over a period of 182 days of follow-up in healthy adults who received full or fractional booster doses of BNT162b2 or AZD1222 after completing a primary series of Sinovac, BNT162b2 or AZD1222. Design: Double-blind, parallel-arm, phase IV randomised trial. Setting: The study was conducted in Campo Grande, Brazil, and participants were recruited in neighbourhoods with the lowest booster vaccine coverage. Follow-up visits were home based. Participants: 1451 (18–60 years) healthy adults who had received a full primary series of Sinovac (n=549), BNT162b2 (n=451) or AZD1222 (n=451) were included. Interventions: Participants were randomised to receive booster doses of either full or fractional doses of BNT162b2, AZD1222 or a full dose of Sinovac in the Sinovac-primed group. Antispike IgG antibody levels were measured at 0, 28, 84 and 182 days post-booster. Main outcome measures: Antispike IgG antibody levels were measured through blood samples at baseline and follow-up visits that were conducted 28, 84 and 182 days post-booster vaccination. Results: Throughout the 182-day follow-up period, full doses of BNT162b2 generated the highest antibody titres compared with fractional doses and other vaccines in all primary groups. Full-dose AZD1222 compared with its fractional dose showed a substantial difference only at day 28. BNT162b2 fractional doses produced higher antibodies than AZD1222 full doses. Sinovac-primed participants had the lowest baseline antibody titres, with Sinovac boosters continuing to show low titres, compared with BNT162b2 or AZD1222 full or fractional doses. Conclusions: Full doses of BNT162b2 consistently elicited higher antibody titres than fractional doses, AZD1222 and Sinovac at all time points. AZD1222 and Sinovac full doses produced lower titres than BNT162b2 fractional doses. Recommendations for using fractional doses of BNT162b2 as an alternative to full doses should be made cautiously, and further studies are needed to determine clinical protection levels. Trial registration number: NCT05343871 .
- Open Access
Optimising COVID-19 Episode Identification Using Serology and PCR/Rapid Antigen Testing: Insights from the BRACE Trial
Background: Accurately identifying COVID-19 episodes was crucial during the pandemic for evaluating interventions. Results from diagnostic tools like PCR, rapid antigen test (RAT) and serology are affected by factors such as timing of tests and vaccination status. The BRACE trial developed an algorithm integrating these diagnostic tools for illness episode classification. Methods: In the BRACE trial, 3988 participants reported 5512 febrile/respiratory illness episodes and provided longitudinal blood samples over one year. SARS-CoV-2 diagnosis relied on a three-component algorithm: (1) a serology algorithm assessing anti-SARS-CoV-2 nucleocapsid antibody seroconversion, (2) a PCR/RAT algorithm, and (3) an episode interpretation algorithm combining serology and PCR/RAT results to categorise episodes as COVID-19, Not COVID-19 or Uncertain. The algorithms accounted for vaccination status and timing of testing relative to symptom onset to refine episode classifications. Results: Of 5512 illness episodes, 890 (16%) were classified as COVID-19, 3852 (70%) as Not COVID-19, and 770 (14%) as Uncertain. Compared to relying solely on PCR/RAT results, integrating serology in the algorithm reduced the proportion of Uncertain classifications by more than half. Among the COVID-19 episodes, 89% were identified by positive PCR/RAT results, and the remaining 11% (with missing or negative PCR/RAT tests) were identified by serology. Discordance between PCR/RAT and serology occurred in 13% of episodes. Conclusion: An algorithm integrating PCR/RAT and serology results in the context of test timing and vaccine status enabled the accurate identification of COVID-19 episodes and minimised the number of episodes that would otherwise have been classified as Uncertain.
Open AccessOptimising COVID-19 Episode Identification Using Serology and PCR/Rapid Antigen Testing: Insights from the BRACE Trial
Background: Accurately identifying COVID-19 episodes was crucial during the pandemic for evaluating interventions. Results from diagnostic tools like PCR, rapid antigen test (RAT) and serology are affected by factors such as timing of tests and vaccination status. The BRACE trial developed an algorithm integrating these diagnostic tools for illness episode classification. Methods: In the BRACE trial, 3988 participants reported 5512 febrile/respiratory illness episodes and provided longitudinal blood samples over one year. SARS-CoV-2 diagnosis relied on a three-component algorithm: (1) a serology algorithm assessing anti-SARS-CoV-2 nucleocapsid antibody seroconversion, (2) a PCR/RAT algorithm, and (3) an episode interpretation algorithm combining serology and PCR/RAT results to categorise episodes as COVID-19, Not COVID-19 or Uncertain. The algorithms accounted for vaccination status and timing of testing relative to symptom onset to refine episode classifications. Results: Of 5512 illness episodes, 890 (16%) were classified as COVID-19, 3852 (70%) as Not COVID-19, and 770 (14%) as Uncertain. Compared to relying solely on PCR/RAT results, integrating serology in the algorithm reduced the proportion of Uncertain classifications by more than half. Among the COVID-19 episodes, 89% were identified by positive PCR/RAT results, and the remaining 11% (with missing or negative PCR/RAT tests) were identified by serology. Discordance between PCR/RAT and serology occurred in 13% of episodes. Conclusion: An algorithm integrating PCR/RAT and serology results in the context of test timing and vaccine status enabled the accurate identification of COVID-19 episodes and minimised the number of episodes that would otherwise have been classified as Uncertain.
- Open Access
- 22 February 2025
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 44, 101031
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil
- 22 February 2025
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 44, 101031
Open AccessImmunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 57, e007022024
High prevalence of syphilis among recyclable waste collectors in Central Brazil
Syphilis is associated with social and behavioral factors.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 57, e007022024
Open AccessHigh prevalence of syphilis among recyclable waste collectors in Central Brazil
Syphilis is associated with social and behavioral factors.
- Open Access
- 10 March 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (3) , e0279390
Cytokine profiling of samples positive for Chlamydia trachomatis and Human papillomavirus
Persistent human papillomavirus (HPV) infection is closely associated with cervical carcinoma. Co-infection in the endocervical environment with other microorganisms, such asChlamydia trachomatis, may increase the risk of HPV infection and neoplastic progression. While in some individuals,Chlamydia trachomatisinfection is resolved with the activation of Th1/IFN-γ-mediated immune response, others develop a chronic infection marked by Th2-mediated immune response, resulting in intracellular persistence of the bacterium and increasing the risk of HPV infection. This work aimed to quantify cytokines of the Th1/Th2/Th17 profile in exfoliated cervix cells (ECC) and peripheral blood (PB) of patients positive forChlamydia trachomatisDNA, patients positive for Papillomavirus DNA, and healthy patients. Cytokine levels were quantified by flow cytometry in ECC and PB samples from patients positive forC.trachomatisDNA (n = 18), patients positive for HPV DNA (n = 30), and healthy patients (n = 17) treated at the Hospital de Amor, Campo Grande-MS. After analysis, a higher concentration of IL-17, IL-6, and IL-4 (p C.trachomatisDNA compared to samples from healthy patients. When comparing samples from patients positive for HPV DNA, there was a higher concentration of cytokines IL-17, IL-10, IL-6, and IL-4 (p C.trachomatisDNA. These results suggest that induction of Th2- and Th17 mediated immune response occurs in patients positive forC.trachomatisDNA, indicating chronic infection. Our results also demonstrate a high concentration of pro-inflammatory cytokines in ECC of patients positive forC.trachomatisDNA.
- 10 March 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (3) , e0279390
Open AccessCytokine profiling of samples positive for Chlamydia trachomatis and Human papillomavirus
Persistent human papillomavirus (HPV) infection is closely associated with cervical carcinoma. Co-infection in the endocervical environment with other microorganisms, such asChlamydia trachomatis, may increase the risk of HPV infection and neoplastic progression. While in some individuals,Chlamydia trachomatisinfection is resolved with the activation of Th1/IFN-γ-mediated immune response, others develop a chronic infection marked by Th2-mediated immune response, resulting in intracellular persistence of the bacterium and increasing the risk of HPV infection. This work aimed to quantify cytokines of the Th1/Th2/Th17 profile in exfoliated cervix cells (ECC) and peripheral blood (PB) of patients positive forChlamydia trachomatisDNA, patients positive for Papillomavirus DNA, and healthy patients. Cytokine levels were quantified by flow cytometry in ECC and PB samples from patients positive forC.trachomatisDNA (n = 18), patients positive for HPV DNA (n = 30), and healthy patients (n = 17) treated at the Hospital de Amor, Campo Grande-MS. After analysis, a higher concentration of IL-17, IL-6, and IL-4 (p C.trachomatisDNA compared to samples from healthy patients. When comparing samples from patients positive for HPV DNA, there was a higher concentration of cytokines IL-17, IL-10, IL-6, and IL-4 (p C.trachomatisDNA. These results suggest that induction of Th2- and Th17 mediated immune response occurs in patients positive forC.trachomatisDNA, indicating chronic infection. Our results also demonstrate a high concentration of pro-inflammatory cytokines in ECC of patients positive forC.trachomatisDNA.
- Open Access
- 17 February 2023
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Saúde Pública
- Vol. 57 (1) , 10
Importância da vacinação contra o papilomavírus humano em um assentamento rural em Terenos, Mato Grosso do Sul
OBJECTIVE: To understand health professionals’ perceptions about vaccination against human papillomavirus (HPV) in the Santa Mônica rural settlement in Terenos, Mato Grosso do Sul. METHODS: Quantitative and qualitative methodologies, consultations on vaccination cards, records of community health agents and the focus group technique were used. The main factors of hesitation and vaccine refusal were analyzed, as well as the health team’s strategies for the process of immunization against HPV, from June to August 2018. RESULTS: Of 121 children and adolescents, 81 (66.94%) received the complete vaccination schedule. Complete vaccination coverage for women was 73.17% (60/82) and for men, 53.8% (21/39). It was observed that, although strategies are adopted for vaccine promotion, such as mobile actions, the public is resistant due to superficial knowledge about the vaccine and its use in an early age group, showing itself to be susceptible to the negative influence of the media and to society’s taboos. In addition, difficulties regarding the use of the Unified Health System card and the shortage of professionals were also observed. CONCLUSION: The results explain the immunization coverage below the target and reinforce the need to strengthen the family health strategy, as well as the permanent and continuing education of professionals, in order to increase parental confidence and adherence to vaccination.
- 17 February 2023
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Saúde Pública
- Vol. 57 (1) , 10
Open AccessImportância da vacinação contra o papilomavírus humano em um assentamento rural em Terenos, Mato Grosso do Sul
OBJECTIVE: To understand health professionals’ perceptions about vaccination against human papillomavirus (HPV) in the Santa Mônica rural settlement in Terenos, Mato Grosso do Sul. METHODS: Quantitative and qualitative methodologies, consultations on vaccination cards, records of community health agents and the focus group technique were used. The main factors of hesitation and vaccine refusal were analyzed, as well as the health team’s strategies for the process of immunization against HPV, from June to August 2018. RESULTS: Of 121 children and adolescents, 81 (66.94%) received the complete vaccination schedule. Complete vaccination coverage for women was 73.17% (60/82) and for men, 53.8% (21/39). It was observed that, although strategies are adopted for vaccine promotion, such as mobile actions, the public is resistant due to superficial knowledge about the vaccine and its use in an early age group, showing itself to be susceptible to the negative influence of the media and to society’s taboos. In addition, difficulties regarding the use of the Unified Health System card and the shortage of professionals were also observed. CONCLUSION: The results explain the immunization coverage below the target and reinforce the need to strengthen the family health strategy, as well as the permanent and continuing education of professionals, in order to increase parental confidence and adherence to vaccination.
- Open Access
Molecular Epidemiology of HIV-1 among Prisoners in Central Brazil and Evidence of Transmission Clusters
Higher rates of human immunodeficiency virus (HIV) infection have been detected in prisoners when compared with the general population, but research into HIV molecular epidemiology and its transmission network has been lacking among them. Thus, this study aimed to verify potential HIV molecular transmission networks among prisoners. In addition, we aimed to describe the mutations related to antiretroviral resistance in these isolates. Thus, we conducted a cross-sectional survey from 2013 to 2018 in prisons in Central-Western Brazil, and the final sampling composed of 84 prisoners. Proviral DNA was extracted from each whole blood sample followed by amplification of the partial polymerase gene and sequencing. Forty-nine sequences (58.3%) were classified as subtype B, followed by C (14.3%), D, and F1 (2.4% each). A complex and dynamic HIV-1 epidemic is observed in the prisons, as 25% of the sequences were recombinant forms. We detected 15 HIV transmission clusters composed of at least two sequences, that included not only prisoners but also individuals from the general population from the same State with a variety of risk behaviors. Thirty-two percent (32.0%) of treatment-experienced prisoners had at least one drug resistance mutation (DRM), while transmitted DRMs were found in 5.9% of the prisoners. We highlight the urgent need for routine surveillance of HIV-1 infection including resistance genotypic tests considering the high disease burden, risky behaviors inside prisons, and the dynamic relationship of prisoners with the outside community.
Open AccessMolecular Epidemiology of HIV-1 among Prisoners in Central Brazil and Evidence of Transmission Clusters
Higher rates of human immunodeficiency virus (HIV) infection have been detected in prisoners when compared with the general population, but research into HIV molecular epidemiology and its transmission network has been lacking among them. Thus, this study aimed to verify potential HIV molecular transmission networks among prisoners. In addition, we aimed to describe the mutations related to antiretroviral resistance in these isolates. Thus, we conducted a cross-sectional survey from 2013 to 2018 in prisons in Central-Western Brazil, and the final sampling composed of 84 prisoners. Proviral DNA was extracted from each whole blood sample followed by amplification of the partial polymerase gene and sequencing. Forty-nine sequences (58.3%) were classified as subtype B, followed by C (14.3%), D, and F1 (2.4% each). A complex and dynamic HIV-1 epidemic is observed in the prisons, as 25% of the sequences were recombinant forms. We detected 15 HIV transmission clusters composed of at least two sequences, that included not only prisoners but also individuals from the general population from the same State with a variety of risk behaviors. Thirty-two percent (32.0%) of treatment-experienced prisoners had at least one drug resistance mutation (DRM), while transmitted DRMs were found in 5.9% of the prisoners. We highlight the urgent need for routine surveillance of HIV-1 infection including resistance genotypic tests considering the high disease burden, risky behaviors inside prisons, and the dynamic relationship of prisoners with the outside community.
- Open Access
Hepatitis B Virus Infection among Japanese Immigrants and Descendants: The Need to Strengthen Preventive and Control Measures
This cross-sectional study aimed to investigate the prevalence and risk factors of Hepatitis B virus infection among Japanese immigrants and their descendants from São Paulo (SP), and to verify the occurrence of occult hepatitis B and coinfection with HCV, Delta, and HTLV. All samples (n = 2.127) were tested for HBV serological markers by electrochemiluminescence. HBsAg and/or total anti-HBc positive samples were tested for HBV DNA by real-time PCR, and genotyped by sequencing using the Sanger methodology. The prevalence rate of HBV exposure was 13.4% (CI 95%: 11.9–14.9%), and 22 (1.1%) were HBsAg positive. A high rate of susceptibility to HBV infection was found (67.4%; CI 95%: 65.4–69.4%). In contrast, only 19.2% (CI 95%: 17.6–20.9%) presented a serological profile analogous to that elicited by Hepatitis B vaccination. HBV isolates (n = 8) were classified as genotypes HBV/B1 (62.5%), HBV/C2 (12.5%), HBV/F1b (12.5%), and HBV/A1 (12.5%). Hepatitis B vaccination strategies and educational measures to control this infection should be considered.
Open AccessHepatitis B Virus Infection among Japanese Immigrants and Descendants: The Need to Strengthen Preventive and Control Measures
This cross-sectional study aimed to investigate the prevalence and risk factors of Hepatitis B virus infection among Japanese immigrants and their descendants from São Paulo (SP), and to verify the occurrence of occult hepatitis B and coinfection with HCV, Delta, and HTLV. All samples (n = 2.127) were tested for HBV serological markers by electrochemiluminescence. HBsAg and/or total anti-HBc positive samples were tested for HBV DNA by real-time PCR, and genotyped by sequencing using the Sanger methodology. The prevalence rate of HBV exposure was 13.4% (CI 95%: 11.9–14.9%), and 22 (1.1%) were HBsAg positive. A high rate of susceptibility to HBV infection was found (67.4%; CI 95%: 65.4–69.4%). In contrast, only 19.2% (CI 95%: 17.6–20.9%) presented a serological profile analogous to that elicited by Hepatitis B vaccination. HBV isolates (n = 8) were classified as genotypes HBV/B1 (62.5%), HBV/C2 (12.5%), HBV/F1b (12.5%), and HBV/A1 (12.5%). Hepatitis B vaccination strategies and educational measures to control this infection should be considered.